Acute Gout Flare

Patient Summary

Is this FDA-cleared for this use?

Not FDA-cleared for acute gout. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is investigational.

What evidence exists?

Tier C (investigational). Two small uncontrolled case series describe rapid pain reduction within 24 to 48 hours; there are no randomized controlled trials. Evidence-based first-line acute-flare therapy per ACR 2020 includes oral or intra-articular corticosteroids (NNT around 2), NSAIDs (where not contraindicated), and oral colchicine within 36 hours of flare onset. Long-term urate-lowering therapy (allopurinol, febuxostat) with target serum urate under 6 mg/dL prevents recurrent flares and tophus formation. Leech therapy does not address the underlying urate burden.

Main risks

• Bleeding from bite sites for 6 to 24 hours after detachment, magnified if NSAIDs are also used
• Local skin infection or, rarely, Aeromonas infection in a tense, inflamed joint area
• Bruising and tenderness for 5 to 10 days
• Worsening of acute joint pain in the first 24 hours
• Allergic reaction to leech saliva (uncommon)
• Small permanent scars at bite sites
• Misdiagnosis of septic arthritis as gout (joint aspiration must be considered)
• Delay of urate-lowering therapy with continued flare recurrence and tophus accumulation

Who should not consider this

• Patients with septic arthritis (must be ruled out by joint aspiration if any doubt)
• Patients with tophus rupture and active discharge
• Patients on anticoagulants, with hemophilia, or with severe anemia
• Patients with active infection or sepsis
• Patients who can tolerate first-line therapy (corticosteroids, NSAIDs, colchicine)
• Patients who have not had a serum urate measured or do not have urate-lowering therapy in place

What to ask your clinician

• Has septic arthritis been ruled out by joint aspiration (especially if monoarthritis, fever, recent procedures)?
• What is my serum urate, and am I on urate-lowering therapy (allopurinol, febuxostat) at goal under 6 mg/dL?
• Have I tried oral or intra-articular corticosteroid, or low-dose colchicine, for this flare?
• Why is leech therapy being offered when first-line therapy is well-tolerated?
• Where exactly will leeches be placed — around but not directly on the inflamed joint?
• What is the practitioner's experience and Aeromonas-prevention plan?
• What is my long-term flare-prevention plan?

When to seek urgent care

• Hot swollen joint with high fever, chills, or feeling systemically unwell (possible septic arthritis — call clinician immediately)
• Inability to bear weight or use the joint
• Rapidly spreading redness up the limb (cellulitis or lymphangitis)
• Bleeding from a bite site lasting more than 24 to 48 hours
• Severe nausea, vomiting, or diarrhea (colchicine toxicity if taking)
• Severe joint pain unresponsive to first-line therapy
• Hives, throat tightness, or breathing difficulty